These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16237046)

  • 1. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
    Mellor AL; Baban B; Chandler PR; Manlapat A; Kahler DJ; Munn DH
    J Immunol; 2005 Nov; 175(9):5601-5. PubMed ID: 16237046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.
    Manlapat AK; Kahler DJ; Chandler PR; Munn DH; Mellor AL
    Eur J Immunol; 2007 Apr; 37(4):1064-71. PubMed ID: 17343295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation.
    Baban B; Hansen AM; Chandler PR; Manlapat A; Bingaman A; Kahler DJ; Munn DH; Mellor AL
    Int Immunol; 2005 Jul; 17(7):909-19. PubMed ID: 15967784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
    Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
    J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologic control of IDO competence in splenic dendritic cells.
    Baban B; Chandler PR; Johnson BA; Huang L; Li M; Sharpe ML; Francisco LM; Sharpe AH; Blazar BR; Munn DH; Mellor AL
    J Immunol; 2011 Sep; 187(5):2329-35. PubMed ID: 21813777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide.
    Chen L; Arora M; Yarlagadda M; Oriss TB; Krishnamoorthy N; Ray A; Ray P
    J Immunol; 2006 Aug; 177(4):2373-83. PubMed ID: 16887999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
    Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
    Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GpC-rich oligonucleotide acts on plasmacytoid dendritic cells to promote immune suppression.
    Volpi C; Fallarino F; Bianchi R; Orabona C; De Luca A; Vacca C; Romani L; Gran B; Grohmann U; Puccetti P; Belladonna ML
    J Immunol; 2012 Sep; 189(5):2283-9. PubMed ID: 22844124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO.
    Wingender G; Garbi N; Schumak B; Jüngerkes F; Endl E; von Bubnoff D; Steitz J; Striegler J; Moldenhauer G; Tüting T; Heit A; Huster KM; Takikawa O; Akira S; Busch DH; Wagner H; Hämmerling GJ; Knolle PA; Limmer A
    Eur J Immunol; 2006 Jan; 36(1):12-20. PubMed ID: 16323249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-dependent protective effects of CpG motifs of bacterial DNA in experimental colitis are mediated by CD11c+ dendritic cells.
    Hofmann C; Dunger N; Grunwald N; Hämmerling GJ; Hoffmann P; Schölmerich J; Falk W; Obermeier F
    Gut; 2010 Oct; 59(10):1347-54. PubMed ID: 20732920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.
    Mellor AL; Chandler P; Baban B; Hansen AM; Marshall B; Pihkala J; Waldmann H; Cobbold S; Adams E; Munn DH
    Int Immunol; 2004 Oct; 16(10):1391-401. PubMed ID: 15351783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.
    Liu YC; Gray RC; Hardy GA; Kuchtey J; Abbott DW; Emancipator SN; Harding CV
    J Immunol; 2010 Apr; 184(7):3367-76. PubMed ID: 20181884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.
    Kerkmann M; Rothenfusser S; Hornung V; Towarowski A; Wagner M; Sarris A; Giese T; Endres S; Hartmann G
    J Immunol; 2003 May; 170(9):4465-74. PubMed ID: 12707322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC; Kuchtey J; Harding CV
    J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CpG-ODNs on phenotype and function of monocyte-derived dendritic cells in chronic hepatitis B.
    Xiang XX; Zhou XQ; Wang JX; Xie Q; Cai X; Yu H; Zhou HJ
    World J Gastroenterol; 2011 Nov; 17(43):4825-30. PubMed ID: 22147985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro.
    Matsumoto K; Terakawa M; Fukuda S; Kato A; Toki S; Shinohara M; Wakiguchi H; Saito H
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():42-50. PubMed ID: 16772726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenase.
    Johnson BA; Kahler DJ; Baban B; Chandler PR; Kang B; Shimoda M; Koni PA; Pihkala J; Vilagos B; Busslinger M; Munn DH; Mellor AL
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10644-8. PubMed ID: 20498068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
    Hemmi H; Kaisho T; Takeda K; Akira S
    J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
    Kahler DJ; Mellor AL
    Handb Exp Pharmacol; 2009; (188):165-96. PubMed ID: 19031026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.
    Baban B; Chandler PR; Sharma MD; Pihkala J; Koni PA; Munn DH; Mellor AL
    J Immunol; 2009 Aug; 183(4):2475-83. PubMed ID: 19635913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.